The latest price target for Yield10 Bioscience (NASDAQ: YTEN) was reported by HC Wainwright & Co. on August 17, 2023. The analyst firm set a price target for $4.00 expecting YTEN to rise to within 12 months (a possible 1149.61% upside). 3 analyst firms have reported ratings in the last year.

The latest analyst rating for Yield10 Bioscience (NASDAQ: YTEN) was provided by HC Wainwright & Co., and Yield10 Bioscience maintained their buy rating.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Yield10 Bioscience, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Yield10 Bioscience was filed on August 17, 2023 so you should expect the next rating to be made available sometime around August 17, 2024.

While ratings are subjective and will change, the latest Yield10 Bioscience (YTEN) rating was a maintained with a price target of $25.00 to $4.00. The current price Yield10 Bioscience (YTEN) is trading at is $0.32, which is out of the analyst’s predicted range.

The latest price target for Yield10 Bioscience (NASDAQ: YTEN) was reported by HC Wainwright & Co. on August 17, 2023. The analyst firm set a price target for $4.00 expecting YTEN to rise to within 12 months (a possible 1149.61% upside). 3 analyst firms have reported ratings in the last year.

The latest analyst rating for Yield10 Bioscience (NASDAQ: YTEN) was provided by HC Wainwright & Co., and Yield10 Bioscience maintained their buy rating.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Yield10 Bioscience, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Yield10 Bioscience was filed on August 17, 2023 so you should expect the next rating to be made available sometime around August 17, 2024.

While ratings are subjective and will change, the latest Yield10 Bioscience (YTEN) rating was a maintained with a price target of $25.00 to $4.00. The current price Yield10 Bioscience (YTEN) is trading at is $0.32, which is out of the analyst’s predicted range.

The latest price target for Yield10 Bioscience (NASDAQ: YTEN) was reported by HC Wainwright & Co. on August 17, 2023. The analyst firm set a price target for $4.00 expecting YTEN to rise to within 12 months (a possible 1149.61% upside). 3 analyst firms have reported ratings in the last year.

The latest analyst rating for Yield10 Bioscience (NASDAQ: YTEN) was provided by HC Wainwright & Co., and Yield10 Bioscience maintained their buy rating.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Yield10 Bioscience, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Yield10 Bioscience was filed on August 17, 2023 so you should expect the next rating to be made available sometime around August 17, 2024.

While ratings are subjective and will change, the latest Yield10 Bioscience (YTEN) rating was a maintained with a price target of $25.00 to $4.00. The current price Yield10 Bioscience (YTEN) is trading at is $0.32, which is out of the analyst’s predicted range.

The latest price target for Yield10 Bioscience (NASDAQ: YTEN) was reported by HC Wainwright & Co. on August 17, 2023. The analyst firm set a price target for $4.00 expecting YTEN to rise to within 12 months (a possible 1149.61% upside). 3 analyst firms have reported ratings in the last year.

The latest analyst rating for Yield10 Bioscience (NASDAQ: YTEN) was provided by HC Wainwright & Co., and Yield10 Bioscience maintained their buy rating.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Yield10 Bioscience, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Yield10 Bioscience was filed on August 17, 2023 so you should expect the next rating to be made available sometime around August 17, 2024.

While ratings are subjective and will change, the latest Yield10 Bioscience (YTEN) rating was a maintained with a price target of $25.00 to $4.00. The current price Yield10 Bioscience (YTEN) is trading at is $0.32, which is out of the analyst’s predicted range.

The latest price target for Yield10 Bioscience (NASDAQ: YTEN) was reported by HC Wainwright & Co. on August 17, 2023. The analyst firm set a price target for $4.00 expecting YTEN to rise to within 12 months (a possible 1149.61% upside). 3 analyst firms have reported ratings in the last year.

The latest analyst rating for Yield10 Bioscience (NASDAQ: YTEN) was provided by HC Wainwright & Co., and Yield10 Bioscience maintained their buy rating.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Yield10 Bioscience, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Yield10 Bioscience was filed on August 17, 2023 so you should expect the next rating to be made available sometime around August 17, 2024.

While ratings are subjective and will change, the latest Yield10 Bioscience (YTEN) rating was a maintained with a price target of $25.00 to $4.00. The current price Yield10 Bioscience (YTEN) is trading at is $0.32, which is out of the analyst’s predicted range.

The latest price target for Yield10 Bioscience (NASDAQ: YTEN) was reported by HC Wainwright & Co. on August 17, 2023. The analyst firm set a price target for $4.00 expecting YTEN to rise to within 12 months (a possible 1149.61% upside). 3 analyst firms have reported ratings in the last year.

The latest analyst rating for Yield10 Bioscience (NASDAQ: YTEN) was provided by HC Wainwright & Co., and Yield10 Bioscience maintained their buy rating.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Yield10 Bioscience, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Yield10 Bioscience was filed on August 17, 2023 so you should expect the next rating to be made available sometime around August 17, 2024.

While ratings are subjective and will change, the latest Yield10 Bioscience (YTEN) rating was a maintained with a price target of $25.00 to $4.00. The current price Yield10 Bioscience (YTEN) is trading at is $0.32, which is out of the analyst’s predicted range.

The latest price target for Yield10 Bioscience (NASDAQ: YTEN) was reported by HC Wainwright & Co. on August 17, 2023. The analyst firm set a price target for $4.00 expecting YTEN to rise to within 12 months (a possible 1149.61% upside). 3 analyst firms have reported ratings in the last year.

The latest analyst rating for Yield10 Bioscience (NASDAQ: YTEN) was provided by HC Wainwright & Co., and Yield10 Bioscience maintained their buy rating.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Yield10 Bioscience, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Yield10 Bioscience was filed on August 17, 2023 so you should expect the next rating to be made available sometime around August 17, 2024.

While ratings are subjective and will change, the latest Yield10 Bioscience (YTEN) rating was a maintained with a price target of $25.00 to $4.00. The current price Yield10 Bioscience (YTEN) is trading at is $0.32, which is out of the analyst’s predicted range.

The latest price target for Yield10 Bioscience (NASDAQ: YTEN) was reported by HC Wainwright & Co. on August 17, 2023. The analyst firm set a price target for $4.00 expecting YTEN to rise to within 12 months (a possible 1149.61% upside). 3 analyst firms have reported ratings in the last year.

The latest analyst rating for Yield10 Bioscience (NASDAQ: YTEN) was provided by HC Wainwright & Co., and Yield10 Bioscience maintained their buy rating.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Yield10 Bioscience, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Yield10 Bioscience was filed on August 17, 2023 so you should expect the next rating to be made available sometime around August 17, 2024.

While ratings are subjective and will change, the latest Yield10 Bioscience (YTEN) rating was a maintained with a price target of $25.00 to $4.00. The current price Yield10 Bioscience (YTEN) is trading at is $0.32, which is out of the analyst’s predicted range.